A button will appear below the video, once finished viewing, that will advance you to the post-test.

This module includes a listing of all MS disease-modifying therapies currently approved by the US FDA, except for the sphingosine 1-phosphate (S1P) receptor modulator ponesimod, which was approved after the presentation was recorded.